Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 7, Number 5, October 2016, pages 167-172

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension

Figures

Figure 1.
Figure 1. Graphical representation of heart rate (mean ± SD) variation before and after 24 weeks of treatment in amlodipine and cilnidipine groups.
Figure 2.
Figure 2. Graphical representation of variation in serum uric acid level (mean ± SD), before and after 24 weeks of treatment in amlodipine and cilnidipine groups.

Tables

Table 1. General Characteristics of Patients of Amlodipine and Cilnidipine Groups
 
ParametersAmlodipineCilnidipine
N4745
Male2523
Female2222
Age (years)52.86 ± 5.8153.14 ± 5.24
Body weight (kg)67.56 ± 10.8567.94 ± 9.59
Height (cm)162.22 ± 6.79162.78 ± 7.19
BMI25.01 ± 5.125.51 ± 2.9

 

Table 2. Comparison Data (SBP, DBP, mean BP, Heart Rate and Serum Uric Acid Level) of Baseline and After 24 Weeks of Treatment in Amlodipine and Cilnidipine Groups Along With Corresponding “Z” Test and P Values
 
AmlodipineCilnidipine
Baseline24th weekZPBaseline24th weekZP
*Significant.
SBP155.65 ± 7.29133.38 ± 6.3919.480.0*155.38 ± 6.76133.38 ± 6.6719.230.00*
DBP93.32 ± 3.9778.32 ± 4.2218.290.00*94.16 ± 4.2779.92 ± 4.2716.660.00*
Mean BP113.83 ± 2.9296.45 ± 3.5226.760.00*114.48 ± 2.6497.71 ± 3.726.090.00*
Heart rate76.88 ± 4.3776.56 ± 3.40.400.6876.96 ± 4.5373 ± 3.284.990.00*
Uric acid5.67 ± 1.315.45 ± 1.340.880.375.94 ± 1.094.54 ± 0.584.280.00*